文献速递特殊人群用药治疗药物监测与药物基因组学

全球临床药理学:全球健康视角

Clinical Pharmacology Worldwide: A Global Health Perspective.
PubMed 文献 · Clin Pharmacol Ther · 2021-05-19

该综述指出中低收入国家疾病负担最重,但临床试验、研究者和本地数据不足,缺乏临床药理学与定量药理学专才及基因组数据,限制精准医学应用。文章介绍非洲培训项目与坦桑尼亚研究者赴美进修案例,强调国际合作、培训与基础设施建设可提升全球健康水平。

要点

  • 中低收入国家临床试验与研究数据不足,缺乏本地临床药理学和药物基因组学专才。
  • 非洲临床药理学与定量药理学培训项目及赴美进修是可复制的能力建设模式。
  • 临床药理学家在全球健康中作用关键,需倡导就业与职业发展路径。

核心结论

  • 临床药理学家在全球健康中扮演关键角色,在中低收入国家发展培训与研究基础设施将极大受益。

研究设计与样本

  • 综述,描述中低收入国家临床药理学能力建设案例,包括非洲培训项目与坦桑尼亚研究者赴美进修经历。

主要发现

  • 中低收入国家死亡与疾病负担最高,但临床试验数量、受训研究者和本地人群研究数据落后于高收入国家。
  • 缺乏本地临床药理学与定量药理学专才、培训机会有限及缺乏本地基因组数据,可能加剧健康不平等并限制精准医学应用。

临床怎么用

  • 可通过临床药理学专长(含药物基因组学)推动临床指南推荐改进。
  • 应开展国际合作以改善培训与基础设施,鼓励本地主导的研究与临床试验。
  • 需倡导临床药理学家的就业机会与职业发展路径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Low- and middle-income countries (LMICs) have the highest rates of mortality and morbidity globally, but lag behind high-income countries in the number of clinical trials and trained researchers, as well as research data pertaining to their populations. Lack of local clinical pharmacology and pharmacometrics expertise, limited training opportunities, and lack of local genomic data may contribute to health inequalities and limit the application of precision medicine. Continuing to develop health care infrastructure, including well-designed clinical pharmacology training and data collection in LMICs, can help address these challenges. International collaboration aimed at improving training and infrastructure and encouraging locally driven research and clinical trials will be of benefit. This review describes several examples where clinical pharmacology expertise could be leveraged, including opportunities for pharmacogenomic expertise that could drive improved recommendations for clinical guidelines. Also described are clinical pharmacology and pharmacometrics training programs in Africa, and the personal experience of a Tanzanian researcher currently on a training sabbatical in the United States, as illustrative examples of how training in clinical pharmacology can be effectively implemented in LMICs. These training efforts will benefit from advocacy for employment opportunities and career development pathways for clinical pharmacologists that are gradually being recognized and developed in LMICs. Clinical pharmacologists have a key role to play in global health, and development of training and research infrastructure to advance this expertise in LMICs will be of tremendous benefit.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Wenning L, Pillai GC, Knepper TC, et al. Clinical Pharmacology Worldwide: A Global Health Perspective. Clin Pharmacol Ther. 2021. PMID: 33893656. doi:10.1002/cpt.2274

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。